A Common PCSK9Haplotype, Encompassing the E670G Coding Single Nucleotide Polymorphism, Is a Novel Genetic Marker for Plasma Low-Density Lipoprotein Cholesterol Levels and Severity of Coronary Atherosclerosis

This publication has 29 references indexed in Scilit:

• The Mystery of PCSK9
  Arteriosclerosis, Thrombosis, and Vascular Biology, 2004
• Apolipoprotein B100 Metabolism in Autosomal-Dominant Hypercholesterolemia Related to Mutations inPCSK9
  Arteriosclerosis, Thrombosis, and Vascular Biology, 2004
• Adenoviral-mediated expression of Pcsk9 in mice results in a low-density lipoprotein receptor knockout phenotype
  Proceedings of the National Academy of Sciences, 2004
• Genetic variants in PCSK9 affect the cholesterol level in Japanese
  Journal of Human Genetics, 2004
• Effects of PPAR??, ?? and ?? haplotypes on plasma levels of lipids, severity and progression of coronary atherosclerosis and response to statin therapy in the lipoprotein coronary atherosclerosis study
  Pharmacogenetics, 2004
• A Comparison of Bayesian Methods for Haplotype Reconstruction from Population Genotype Data
  American Journal of Human Genetics, 2003
• Mutations in PCSK9 cause autosomal dominant hypercholesterolemia
  Nature Genetics, 2003
• The secretory proprotein convertase neural apoptosis-regulated convertase 1 (NARC-1): Liver regeneration and neuronal differentiation
  Proceedings of the National Academy of Sciences, 2003
• Bayesian Analysis of Haplotypes for Linkage Disequilibrium Mapping
  Genome Research, 2001
• A Third Major Locus for Autosomal Dominant Hypercholesterolemia Maps to 1p34.1-p32
  American Journal of Human Genetics, 1999